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Résumé de thèse 
Le syndrome de PFAPA est une maladie fébrile récurrente décrite pour la première fois en 1987 par 
Marshall et col. Elle est caractérisée par une fièvre périodique, une stomatite aphteuse, une 
pharyngite et des adénopathies. Ce syndrome débute dans les premières années de vie et est connu 
pour disparaître spontanément en principe avant l'adolescence. Hormis un traitement de prednisone 
en début de crise, aucun traitement n'a pu montrer une efficacité thérapeutique ou curative. 
L'origine et l'étiologie de cette maladie sont encore inconnues à ce jour et le diagnostic reste un 
diagnostic d'exclusion qui repose sur des critères définis par différents groupes depuis 1987. Dans le 
cadre du Working Party periodic fever de la Société Européenne de Rhumatologie pédiatrique (PreS), 
un groupe a été établi et celui-ci a mis en place un registre de patients atteints de PFAPA afin 
d'analyser cette maladie et de mieux définir les critères diagnostic. Le Dr Michael Hofer a été nommé 
chairman de ce groupe et a introduit rapidement les patients romands dans cet outil de travail. 
L'introduction des patients romands dans la base de données ainsi créée, nous a suggéré une 
susceptibilité familiale qui nous a poussés à investiguer ce point de manière plus approfondie. Nous 
avons donc regroupé tous les patients lausannois et ceux de collègues bordelais ayant un diagnostic 
avéré de PFAPA. Nous avons ensuite interrogé, au cours d'un entretien téléphonique, les familles de 
ces enfants grâce à un questionnaire standardisé. Celui-ci a été testé et validé sur des patients sains 
d'une consultation de pédiatrie générale. 
Nous avons ensuite réunie toutes ces informations et séparés les patients en deux groupes AF+ 
(anamnèse familiale positive pour une fièvre récurrente) et AF- (anamnèse familiale négative pour 
une fièvre récurrente). Nous avons établi des comparaisons entre les 2 différents groupes en 
reprenant les caractéristiques de ces patients depuis le registre PFAPA dans lequel ils sont tous 
inclus. Les analyses ont été contrôlées et validées par le centre d'épidémiologie clinique grâce aux 
méthodes statistiques reconnues. 
Les résultats obtenus et qui sont détaillés dans l'article, permettent de suspecter une origine 
familiale et par là même, potentiellement génétique, à cette maladie d'étiologie inconnue. Jusqu'à 
présent aucune prépondérance familiale n'avait pu être mise en évidence dans les autres études sur 
le sujet. Pourtant cette maladie fait partie du groupe des fièvres récurrentes qui ont pour beaucoup 
déjà un diagnostic génétique. 
Notre étude ouvre donc des perspectives non seulement de recherche sur l'éventuelle cause 
génétique mais pourrait également permettre une meilleure compréhension de la maladie, de ses 
diverses présentations ainsi que par la suite de nouvelles possibilités thérapeutiques. 
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PFAPA syndrome is not a sporadic disease 
Marie Cochard1•2 , Johanna Clet3, Lan le 1•2 , Pascal Pillet3 , Xavier Onrubia4 , 
Thierry Guéron4 , Mohammed Faouzi5 and Michaël Hoter 1•2 
Abstract 
Objectives. To determine whether PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical 
adenitis) patients have a positive family history (FH) for recurrent fever syndromes. 
Method. For ail patients with PFAPA seen in two paediatric rheumatology centres (Romandy, Switzerland 
and Bordeaux, France), parents were interviewed to record the FH for periodic fever. As contrais, we 
interviewed a group of children without history of recurrent fever. 
Results. We recruited 84 patients with PFAPA and 47 healthy children. The FH for recurrent fever (without 
an infectious cause and recurring for at least hait a year) was positive in 38/84 (45%), and was positive for 
PFAPA (diagnosis confirmed by a physician) in 10/84 (12%) of the PFAPA patients. For 29 of the 
38 patients with positive FH, the affected persan was a sibling or a parent. None of the healthy children 
had a positive FH for recurrent fever or PFAPA. A positive FH for rheumatological diseases was seen in 
bath groups of children. 
Conclusion. These data show that a significant percentage of PFAPA patients present a positive FH of 
recurrent fever and PFAPA. This familial susceptibility suggests a potential genetic origin for this 
syndrome. 
Key words: Heredity, Child, Auto-inflammatory disease, Periodic fever. 
Introduction 
PFAPA syndrome (periodic fever, aphthous stomatitis, 
pharyngitis and cervical adenitis) is a recurrent febrile dis-
ease first described in 1987 by Marshall et al. [1]. lt is 
characterized by fever episodes, lasting for 3-6 days 
with a recurrence every 3-8 weeks, and accompanied 
by aphthous stomatitis, pharyngitis or cervical adenitis 
[2]. No specific diagnostic test for PFAPA is available 
and the diagnosis is based on published diagnostic cri-
teria [2, 3]. The patient should not present any upper re-
spiratory tract infection, must be totally asymptomatic 
between the episodes and present normal growth and 
development. Various febrile diseases should be 
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excluded, like recurrent infections, immunodeficiency, 
Still's disease, haematological diseases and monogenic 
auto-inflammatory diseases [3]. 
Since the first description of PFAPA, no clear aetiology 
has been found and it is considered a sporadic disease 
[3-5]. The exact prevalence of this syndrome is not known 
but PFAPA seems to be far more frequent than other 
auto-inflammatory diseases [2, 3]. 
To better understand PFAPA syndrome, in 2007 we es-
tablished a European registry with the participation of 
8 countries and 14 rheumatological centres [6]. A prelim-
inary analysis of the data showed a surprisingly high 
number of patients with a positive family history (FH) for 
recurrent fever. Based on this observation, we decided to 
investigate more precisely the FH of PFAPA patients in 
order to determine whether there is a familial predomin-
ance in this syndrome. 
Patients and methods 
From centres participating in the European PFAPA regis-
try, we included all patients from Romandy (n==46) and 
Bordeaux (n == 39). The patients were diagnosed accord-
ing to previously published diagnostic criteria [2, 3]. 
©The Author 2010. Publlshed by Oxford University Press on behalf of the British Society for Rheumato!ogy. AU rights reserved_ For Permlssions, please ernalf: )ournals.pennJsslons@oxfordjourna!s.org 
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Ali patients had recurring fever episodes with a median 
maximum temperature of 40°C, and at least one of the 
cardinal symptoms (pharyngitis, cervical adenitis and 
oral aphthosis); 35/84 presented all three symptoms. Ali 
patients were in a good general condition between the 
fever attacks and they showed normal growth and devel-
opment. Monogenic auto-inflammatory diseases were 
excluded by clinical presentation, completed by labora-
tory tests if necessary. Genetie testing for common peri-
odic fevers was performed by DNA sequencing of the 
most clinically relevant exons. 
Ali parents were asked for the FH of the patient during a 
5- to 10-min phone interview. Questions were asked fol-
lowing a questionnaire with a list of items: FH for recurrent 
fever (without an infectious cause and recurring for at least 
half a year), PFAPA syndrome (diagnosis confirmed by 
a physician), chronic inflammatory rheumatological dis-
eases and psoriasis. When a question was answered 
positively, we asked for the family rani< of the affected 
person and if the diagnosis was confirmed by a physician. 
We performed the same interview on children without a 
history of recurrent febrile attacks or chronic disease and 
who attended the consultation of one of the three paedia-
tricians participating in the study. These children were 
randomly selected among those consulting for regular 
control of their development or an acute illness. The 
study was approved by our local ethics committee 
(Commission d'Éthique de la Recherche Clinique du 
CHUV) and the parents gave their informed consent for 
the study. 
Statistica~ methods 
Analyses were conducted using STATA 10.1 (Stata Corp., 
College Station, TX, USA). To examine bivariate associ-
ations between two variables, we used Fisher's exact test 
when the two variables were categorical, and a 
non-parametric Wilcoxon test if one was continuous and 
the second was categorical. The difference between 
FH-positive (FW) and FH-negative (FW) patients was 
analysed using logistic regression. Significant bivariate 
predictors (P < 0.1) were included in a multivariate logistic 
regression. 
Results 
We were able to contact the parents of 84 out of our 
85 PFAPA patients and all agreed to answer the ques-
tions. The mean age at the time of the interview was 
7.5 years (2-25 years) with a girl to boy ratio of 1 : 1.4 for 
the PFAPA patients; 6.9 years (4-13 years) and 1 : 1.35 for 
the 47 healthy children. Monogenic auto-inflammatory 
diseases were excluded by the clinical presentation 
in 64 patients and by genetic testing in 20 patients 
[îumor necrosis factor receptor-associated periodic syn-
drome (TRAPS): 12; FMF: 14; HyperlgD syndrome: 3; 
Cryopyrin-associated periodic syndrome: 1]. 
A positive FH for recurrent fever was found in 38/84 
(45%) of the PFAPA patients. ln 29/38 (76%) of the pa-
tients, the affected family member was a sibling or parent. 
2 
ln 10/38 (26%) patients, the recurrent fever syndrome in 
the family member was diagnosed as PFAPA by a phys-
ician. ln 3/38 (8%) patients a FMF was reported, and in 2 
of them the father was affected and the PFAPA patient 
was heterozygous for M694V. ln one of the patients with 
positive FH for FMF, the affected father and uncle were 
followed in childhood by the same paediatric rheumatolo-
gist, and the diagnosis was confirmed by genetic testing. 
ln 25/38 (66%), the affected family member reported re-
current fever without an established diagnosis. Seven 
PFAPA patients had two family members with recurrent 
fever (PFAPA: one, FMF: two, recurrent fever: four). 
Among the 64 patients with PFAPA diagnosed by clinical 
presentation, the percentage of FH+ 26/64 (41 %) was 
lower than in the group of patients who had genetic test-
ing, 12/20 (60%). 
ln the group of healthy children, the FH was com-
pletely negative for recurrent fever and PFAPA. A positive 
FH for rheumatological diseases (RA: 8; seronegative arth-
ritis: 11; rhizomelic pseudopolyarthritis: 1; lupus: 2; scler-
oderma: 1; Hashimoto: 1) was found more frequently in 
the PFAPA patients [19/84 (23%)] than in the healthy chil-
dren group [5/47 (11 %)] (cf. Fig. 1), but the difference was 
not statistically significant. Psoriasis was found in equal 
proportion in both groups of children. 
We analysed the origin of the parents of the FW and FH-
patients and the healthy children: for the majority both par-
ents originated from the country of living (France or 
Switzerland) in the three groups of children. We then eval-
uated whether FH+ and FH- patients could correspond to 
two distinct subsets of PFAPA (Fig. 2). Bivariate logistic 
regression did not show any significant difference in the 
age of onset, symptom duration, sex ratio, maximal 
F1G. 1 Percentage of children with positive FH for PFAPA, 
recurrent fever and rheumatological diseases in PFAPA 
patients and in healthy children. 
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Fia. 2 Frequency of clinical features in FH+ and in FH-
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temperature during the fever episodes or presenting 
symptoms except for headache [Odds Ratio (OR)= 2.54, 
P = 0.076], abdominal pain (OR= 3.38, P = 0.011) and 
vomiting (OR= 3.46, P= 0.089). ln the multivariate analysis, 
only abdominal pain was still significantly associated with 
FW. The frequency of the complete PFAPA cluster (pres-
ence of ail three main clinical symptoms: pharyngitis, cer-
vical adenitis and aphthous stomatitis) was similar in FW 
(44.1%) and in FW (42.2%) patients. 
Discussion 
With this study, we show that nearly half of our PFAPA 
patients have a positive FH for recurrent fever. Most of 
these family members reported a recurrent fever of un-
known origin similar in clinical presentation to the affected 
chi Id, but in 10 patients the family member had an estab-
lished diagnosis of PFAPA. ln previous series of PFAPA 
patients no familial tendency for periodic fever was men-
tioned [3, 7], but three families with two siblings diagnosed 
with PFAPA were recently reported [8, 9]. The FH for re-
current fever was always negative in the healthy children 
suggesting that recurrent fever and PFAPA are not fre-
quently found in the general population. Since in 76% of 
the FH+ patients the affected relative was a parent or a 
sibling, it is very unlikely that a positive FH would have 
been missed in the healthy children. ln contrast to recur-
rent fever, a FH for rheumatological diseases and psoria-
sis was positive in bath PFAPA patients and healthy 
www.rheumatology.oxfordjournals.org 
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children. For rheumatological diseases, we found a trend 
of more frequent positive FH in PFAPA patients, but with-
out a significant difference between the two groups. This 
observation may suggest that PFAPA patients show an 
increased susceptibility to inflammatory diseases, as we 
could also describe in an adult patient with bath PFAPA 
and SpA (Cochard M et al., 2010, data not published). 
PFAPA syndrome is one of the auto-inflammatory dis-
eases with recurrent fever like TRAPS, FMF, Hyper-lgD 
syndrome, cryopyrin-associated periodic syndrome. A 
genetic origin was found for these diseases except for 
PFAPA, where no clear aetiology has been found so far 
[3]. ln most of our patients, the clinical presentation was 
clear enough to confirm the diagnosis of PFAPA and gen-
etic testing was performed in only a minority of the pa-
tients. The rate of positive FH was higher for this group of 
patients than for the group of clinically diagnosed pa-
tients, showing that despite laboratory exclusion of mono-
genic auto-inflammatory diseases there is still a high 
familial predominance for recurrent fever in PFAPA 
syndrome. 
Our study showed some methodological limitations, be-
cause the diagnosis of PFAPA is based on clinical criteria 
and the low prevalence did not allow us to perform the 
study prospectively. Furthermore, FH has to rely on the 
memory of the persan asked and may be incomplete 
owing to insufficient knowledge about the diseases pre-
sented by other family members. ln our study, the FH was 
taken by a limited number of physicians and based on 
phone interviews performed in a limited period of time, 
ensuring data consistency. As discussed above, the ma-
jority of the affected family members were closely related 
to the patient, limiting the risk of inaccurate data. PFAPA 
syndrome usually has a benign long-term outcome; thus, 
expensive genetic testing in ail patients is not justified. As 
positive FH is also markedly present in the patients tested 
genetically, we believe that the way in which patients were 
diagnosed did not bias the results of our study. 
lnterestingly, three of our PFAPA patients reported 
family members with FMF. ln these patients, FMF could 
be excluded by the clinical presentation, genetic testing 
and outcome. The possible predisposition for PFAPA in 
the case of a heterozygous mutation of the MEFV gene 
has already been studied [10]. ln a first paper, MEFV mu-
tations were searched in for six unrelated children with 
PFAPA and the results argued against the involvement 
of MEFV in PFAPA syndrome [5]. Recently, Kone-Paut 
et al. [11] reported the clinical spectrum of 94 MEFV het-
erozygous patients with recurrent fever: 4 patients had 
typical features for PFAPA syndrome and 3 of !hem re-
sponded well to colchicine. The familial predominance of 
PFAPA was no! related to a specific ethnie background in 
our cohort, suggesting that the origin of the family did not 
play a raie in the susceptibility for the disease. We exam-
ined the profile of bath FW and FH- PFAPA patients, to 
evaluate whether they correspond to two different subsets 
of PFAPA syndrome. For clinical presentation, gender re-
partition, and age of disease onset, bath FW and FH-
groups were similar; we only found a significant difference 
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for abdominal pain, which is a common symptom in 
PFAPA syndrome [12]. 
With this study, we show for the first time a familial 
susceptibility to PFAPA syndrome, suggesting a potential 
genetic origin. Therefore, our study reinforces the interest 
of further investigations on a genetic marker for PFAPA 
syndrome, which would represent a great help for diag-
nosis. Furthermore, if such a marker were available, stu-
dies on the effect of different therapies and on the 
long-term outcome could be performed on patients with 
a clear diagnosis of PFAPA. 
Disclosure statement: The authors have declared no con-
flicts of interest. 
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